首页> Clinical cancer research : an official journal of the American Association for Cancer Research> Significance of BRCA2 and RB1 Co-loss in Aggressive Prostate Cancer Progression.

Significance of BRCA2 and RB1 Co-loss in Aggressive Prostate Cancer Progression.

导出 OA

翻译打印收藏纠错

第一作者： Goutam,Chakraborty

第一单位： Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

作者： Goutam,Chakraborty ^[1] ; Joshua,Armenia ^[2] ; Ying Z,Mazzu ^[1] ; Subhiksha,Nandakumar ^[2] ; Konrad H,Stopsack ^[1] ; Mohammad O,Atiq ^[1] ; Kazumasa,Komura ^[3] ; Lina,Jehane ^[1] ; Rahim,Hirani ^[1] ; Kalyani,Chadalavada ^[4] ; Yuki,Yoshikawa ^[1] ; Nabeela A,Khan ^[1] ; Yu,Chen ^[5] ; Wassim,Abida ^[1] ; Lorelei A,Mucci ^[6] ; Gwo-Shu Mary,Lee ^[7] ; Gouri J,Nanjangud ^[4] ; Philip W,Kantoff ^[8]

作者单位： Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. ^[1] Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. ^[2] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.;Department of Urology, Osaka Medical College, Osaka, Japan. ^[3] Molecular Cytogenetics Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York. ^[4] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.;Human Oncology Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. ^[5] Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. ^[6] Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts. ^[7] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. kantoff@mskcc.org. ^[8]

主题词 BRCA2蛋白质(BRCA2 Protein);基因, BRCA2(Genes, BRCA2);人类(Humans);男(雄)性(Male);表型(Phenotype)

DOI 10.1158/1078-0432.CCR-19-1570

PMID 31796516

发布时间 2021-05-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交